CLASS II Drug recall · Reported 6 Mar 2013 · FDA Enforcement Report
Citalopram tablets USP, 20mg recalled by Dr. Reddy's Laboratories
Dr. Reddy's Laboratories is recalling Citalopram tablets USP, 20mg, distributed nationwide in the US. The recall was initiated on 1 Aug 2012 and the FDA has classified it as Class II.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-179-2013
- FDA event ID
- 63285
- Recalling firm
- Dr. Reddy's Laboratories, Bridgewater, NJ
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- 1 Aug 2012
- FDA classified
- 28 Feb 2013
- Reported
- 6 Mar 2013
- Type
- Voluntary: Firm initiated
- Customers notified by
- Letter
- Reason category
- Other Reasons
- Drug class
- Antidepressants
Timeline
| 1 Aug 2012 | Recall initiated by company | |
| 28 Feb 2013 | Classified by FDA | +211 days |
| 6 Mar 2013 | Published in enforcement report | +6 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Chemical Contamination: The product is being recalled due to complaints reporting a strong garlic odor or strong chemical smell.
Product as listed by the FDA
Citalopram tablets USP, 20mg, 30-count bottle, Rx only, Manufactured by Dr. Reddy's Laboratories Limited, Bachupalli, India 502 325, NDC 55111-343-30
Where it was distributed
Nationwide
Questions about this recall
Why was it recalled?
Chemical Contamination: The product is being recalled due to complaints reporting a strong garlic odor or strong chemical smell.
Which lots are affected?
Lot #: C201922, Exp 1/14
Where was it sold?
Nationwide
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
Other products in this recall event
2 other products · FDA event 63285This product is part of a recall event; the main page for the event is Citalopram tablets USP, 40mg recalled by Dr. Reddy's Laboratories.
| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| CLASS II | Citalopram tablets USP, 40mg recalled by Dr. Reddy's Laboratories | Dr. Reddy's Laboratories | Other | Nationwide | |
| CLASS II | Citalopram tablets USP, 10mg recalled by Dr. Reddy's Laboratories | Dr. Reddy's Laboratories | Other | Nationwide |
More recalls from Dr. Reddy's Laboratories
All 165| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS III | Varenicline Tablets, 1mg recalled by Dr. Reddy's LaboratoriesVarenicline Tartrate | Dr. Reddy's Laboratories | Potency & Assay | Nationwide |
| Drug | CLASS II | Succinylcholine Chloride Injection, USP, 200 mg/ (20 mg/mL) recalledSuccinylcholine | Dr. Reddy's Laboratories | Potency & Assay | Nationwide |
| Drug | CLASS II | Omeprazole Delayed-release Capsules, USP, 20mg recalledOmeprazole | Dr. Reddy's Laboratories | Other | Nationwide |
| Drug | CLASS I | Levetiracetam 0.75% in Sodium Chloride Injection 1,000 mg recalledLevetiracetam | Dr. Reddy's Laboratories | Labeling Errors | Nationwide |
| Drug | CLASS III | Javygtor (sapropterin dihydrochloride) Tablets 100mg recalledJavygtor | Dr. Reddy's Laboratories | Potency & Assay | Nationwide |
Other Citalopram recalls
All 6| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Citalopram Tablets, USP, 20MG recalled by Cardinal HealthcareCitalopram | Cardinal Healthcare | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS III | Citalopram Oral Solution, USP 20 mg/ unit dose cups recalled | PAI Holdings | Potency & Assay | Nationwide |
| Drug | CLASS II | Citalopram Tablet, 10 mg recalled by Aidapak Services | Aidapak Services | Labeling Errors | 4 states |
| Drug | CLASS II | Citalopram tablets USP, 10mg recalled by Dr. Reddy's Laboratories | Dr. Reddy's Laboratories | Other | Nationwide |
| Drug | CLASS II | Citalopram tablets USP, 40mg recalled by Dr. Reddy's Laboratories | Dr. Reddy's Laboratories | Other | Nationwide |